Lantheus Holdings, Inc. (LNTH) Stock Analysis
A live, multi-source view of Lantheus Holdings, Inc. (LNTH): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer.
Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic · United States · 1,193 employees · lantheus.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Lantheus Holdings, Inc. (LNTH) had a market capitalization of $6.59B, a trailing P/E of 24.2 (forward 15.8) and a beta of -0.03; the shares traded in a 52-week range of $49.67 – $111.86 (88.3% over the year).
- Market cap
- $6.59B
- Enterprise value
- $6.62B
- Trailing P/E
- 24.2
- Forward P/E
- 15.8
- Price / book
- 5.02
- EPS (trailing)
- $4.18
- EPS (forward)
- $6.38
- Payout ratio
- 0.0%
- 52-week range
- $49.67 – $111.86
- 52-week change
- 88.3%
- Beta
- -0.03
- Average volume
- 1.3M
- Shares outstanding
- 65.3M
- Short % of float
- 10.44%
- Profit margin
- 17.7%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Lantheus Holdings, Inc. (LNTH) last closed at $100.39 (the last completed close before that scan).
Technicals at the scan: RSI 44 (neutral territory), price -0.3% versus its 20-day average, 20-day versus 50-day average spread -1.8%, MACD histogram 0.09.
Sentiment inputs: StockTwits 100% bullish; analyst consensus score 60/100.
Next scheduled company event: in 55 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
RapidTradeView has recorded no Congress or insider filing for LNTH in the last 90 days. Coverage of House, Senate and SEC Form 4 filings began in July 2026, and insider sells are tracked for universe tickers only, so this is our record, not a guarantee that nothing was filed. Who is trading what
RapidTradeView pick record
LNTH has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Lantheus Holdings, Inc. (LNTH) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell LNTH.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.